Ardent Health, Inc. ARDT
10.54
0.06
0.57%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 19.2×
Follow ARDT
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 4.61% | 8.14% | 8.47% | 13.59% |
+8 more TTM periods Free account |
|
| 1.52% | 2.64% | 2.65% | 4.12% | ||
ROIC |
7.59% | 9.49% | 9.80% | 11.10% | |
Return on Tangible Assets |
3.91% | 6.74% | 6.97% | 10.78% | |
Average Days of Receivables |
39.65 | 38.95 | 39.60 | 42.09 | |
Free Cash Flow per Share |
2.15 | 1.54 | 1.84 | 1.12 | |
Free Cash Flow |
304.76 | 217.99 | 258.61 | 157.46 | |
Capital Expenditures |
(209.56) | (217.08) | (211.90) | (209.18) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
14.40% | 12.59% | 13.46% | 10.95% | |
Accounts Receivable Turnover |
8.81 | 8.79 | 8.85 | 8.82 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.19) | (0.20) | (0.20) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
78.48% | 77.51% | 78.00% | 77.45% | |
Share Based Compensation of Revenue |
0.56% | 0.61% | 0.62% | 0.62% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
6.57 | 3.24 | 3.46 | 1.79 | |
Depreciation/Fixed assets |
0.18 | 0.18 | 0.17 | 0.18 | |
Capex/Depreciation |
(1.25) | (1.30) | (1.32) | (1.33) | |
Revenue per Share |
45.21 | 45.51 | 44.93 | 44.79 | |
Operating CF per Share |
3.63 | 3.08 | 3.34 | 2.60 | |
Capex per Share |
(1.48) | (1.54) | (1.51) | (1.48) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
1.22% | 2.09% | 2.15% | 3.24% |
Columns are period end dates